HIF Transcription Factor Expression and Induction of Hypoxic Response Genes in A Retroperitoneal Angiosarcoma

Anticancer Research

Volumn 24, Issue 1, 2004, Pages 167-169

  Rathmell, W Kimryn ^a   Acs, Geza ^b   Simon, M Celeste ^c   Vaughn, David J ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Angiosarcoma; Endothelium; HIF1; HIF2; Hypoxia inducible factor; Retroperitoneal mass; Vascular endothelial growth factor; VEGF; VHL; Von Hippel Lindau

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN;

ADULT; ARTICLE; AUTOCRINE EFFECT; CASE REPORT; ENDOTHELIUM; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RETROPERITONEAL SARCOMA; RETROPERITONEUM; TUMOR GROWTH; UPREGULATION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMANGIOSARCOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; RETROPERITONEAL NEOPLASMS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 1442326133     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mordkin RM, Dahut WL and Lynch JH: Renal angiosarcoma: a rare primary genitourinary malignancy. Southern Medical J 90: 1159-60, 1997.
2. Hiratsuka Y, Nishimura H, Kajiwara I et al: Renal angiosarcoma: a case report. International J Urology 4: 90-3, 1997.
3. Cason JD, Waisman J and Plaine L: Angiosarcoma of kidney. Urology 30: 281-3, 1987.
4. Martinez-Pineiro L, Lopez-Ferrer P, Picazo M et al: Primary renal angiosarcoma. Case report and review of the literature. Scand J Urol Nephrol 29: 103-108, 1995.
5. Amo Y, Masuzawa M, Hamada Y et al: Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISA-HAS). Arch Dermatol Res 293: 296-301, 2001.
6. Zietz C, Rossle M, Haas C et al: MDM-2 oncoprotien overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am J Pathol 153: 1425-1433, 1998.
7. Pugh CW and Ratcliffe PJ: The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Seminars Cancer Biol 13: 83-9, 2003.
8. Pugh CW, Maxwell PH, Harris AL et al: Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Oncogene 19: 6297-305, 2000.
9. Iliopoulos O, Levy AP, Jiang C et al: Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Nat Acad Sci USA 93: 10595-9, 1996.
10. Ohh M, Yang H, Klco JM et al: HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.[comment]. Human Molec Genetics 10: 1019-27, 2001.
11. Masson N, Mole DR, Jaakkola P et al: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.[comment]. J Biological Chem 275: 25733-41, 2000.
12. Tanimoto K, Makino Y, Pereira T et al: Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 19: 4298-309, 2000.
13. Simons JW and Zhong H: Overexpression of hypoxia-inducible factor lalpha in common human cancers and their metastases. Biochem Biophys Res Commun 259: 523-6, 1999.
14. Maher ER and Wiesener MS: Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-lalpha in clear cell renal carcinomas. Adv Cancer Res 82: 85-105, 2001.
15. Liu MY, Poellinger L and Walker CL: Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Cancer Res 63: 2675-80, 2003.
16. Zhong H, Chiles K, Feldser D et al: Modulation of hypoxia-inducible factor lalpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60: 1541-5, 2000.
17. Tsuzuki Y, Fukumura D, Oosthuyse B et al: Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1a-hypoxia response element-VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 60: 6248-6252, 2000.
18. Mack FA, Rathmell WK, Arsham AM et al: Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth. Cancer Cell 3: 75-88, 2003.
19. Tsai JC ZJ, Minami T, Voland C, Zhao S, Yi X, Lassalle P, Oettgen P and Aird WC: Cloning and characterization of the human lung endothelial-cell-specific molecule-1 promoter. J Vasc Res 39: 148-159, 2002.
20. Ma W, Tessarollo L, Hong S et al: Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. Cancer Res 63: 5320-5328, 2003.
21. Onda H, Crino PB, Zhang H et al: Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway. Molec Cell Neurosciences 21: 561-74, 2002.